Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumors 2Advanced Solid Tumors 2Relapsed Pediatric Solid Tumor 1Refractory or Recurrent Solid Tumors, Excluding CNS Tumors 1Mesothelioma, Malignant 1Mesothelioma 1

Interventions

Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Refractory or Recurrent Solid Tumors, Excluding CNS Tumors × Axitinib × Other solid neoplasm × Clear all
NCT02164838 2018-01-29

VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors

Children's Oncology Group

Phase 1 Completed
51 enrolled
Other solid neoplasm

Refractory or Recurrent Solid Tumors, Excluding CNS Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡